Effects of glucosamine against morphine-induced antinociceptive tolerance and dependence in mice

J Biomed Sci. 2019 Feb 19;26(1):21. doi: 10.1186/s12929-019-0513-1.

Abstract

Background: The most important limitations of morphine in pain therapy are its tolerance and dependence. In this study, we evaluated the protective effect of glucosamine against morphine-induced tolerance and dependence in mice.

Methods: Mice received twice daily morphine (20 mg/kg, s.c.) alone, or along with orally administered glucosamine (500, 1000 and 2000 mg/kg), for 9 continuous days. To assess antinociceptive effect of morphine, percentage of maximal possible effect (%MPE) of animals exposed to thermal stimulus was measured in the hot plate test, 30 min after morphine administration. Test was performed on days 1, 3, 5, 7 and 9. The effect of glucosamine on the naloxone (5 mg/kg, i.p.)-precipitated morphine withdrawal, was also evaluated. Changes in brain gene expression levels of induced nitric oxide synthase (iNOS), enzyme responsible for nitric oxide generation, as well as pro-inflammatory mediator, tumor necrosis alpha (TNF-α) were measured in morphine tolerated animals, as well as after withdrawal by real-time polymerase chain reaction (RT-PCR). Protein content of TNF-α was evaluated via ELISA assay.

Results: Tolerance to antinociceptive effect of morphine was developed after 7 days of morphine treatment. The concurrent administration of glucosamine (500, 1000 and 2000 mg/kg) with morphine, significantly inhibited tolerance development, on days 7 and 9. In addition, glucosamine ameliorated the naloxone-precipitated opioid withdrawal symptoms (tremor, jumping, teeth chattering, grooming). However, diarrhea was significantly improved only with the dose of 500 mg/kg. Increased mRNA expression of iNOS as well as TNF-α mRNA expression and protein, after both morphine tolerance and withdrawal, were considerably reduced by glucosamine (1000 mg/kg) in the morphine withdrawal animals.

Conclusion: These data support the utility of glucosamine in attenuating both tolerance to nociceptive effects of morphine as well as withdrawal-induced behavioral profile. Anti-oxidant and anti-inflammatory effects are responsible, at least in part, for the protective effects of this drug.

Keywords: Dependence; Glucosamine; Mice; Morphine; Tolerance.

MeSH terms

  • Analgesics / pharmacology
  • Animals
  • Drug Tolerance*
  • Enzyme-Linked Immunosorbent Assay
  • Glucosamine / pharmacology*
  • Male
  • Mice
  • Morphine / pharmacology
  • Naloxone / pharmacology*
  • Narcotic Antagonists / pharmacology*
  • Nitric Oxide / genetics
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / genetics
  • Nitric Oxide Synthase Type II / metabolism
  • Reactive Nitrogen Species / metabolism
  • Real-Time Polymerase Chain Reaction
  • Substance-Related Disorders / physiopathology*
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Analgesics
  • Narcotic Antagonists
  • Reactive Nitrogen Species
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide
  • Naloxone
  • Morphine
  • NOS2 protein, human
  • Nitric Oxide Synthase Type II
  • Glucosamine